Patterson Companies Inc.

07/06/2022 | Press release | Distributed by Public on 07/06/2022 16:46

Statement of Changes in Beneficial Ownership (Form 4)

Ownership Submission
FORM 4
Check this box if no longer subject to Section 16, Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287Expires:January 31, 2005Estimated average burden hours per response...0.5
1. Name and Address of Reporting Person *
POHLMAN KEVIN M
2. Issuer Name and Ticker or Trading Symbol
PATTERSON COMPANIES, INC. [PDCO] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
President - Animal Health /
(Last) (First) (Middle)
822 7TH STREET, SUITE 740
3. Date of Earliest Transaction (Month/Day/Year)
(Street)
GREELEY CO 80631
4. If Amendment, Date Original Filed(Month/Day/Year)
 6. Individual or Join/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code 4. Securities Acquired (A) or Disposed of (D) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) 6. Ownership Form: Direct (D) or Indirect (I) 7. Nature of Indirect Beneficial Ownership
Code V Amount (A) or (D) Price
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code 5. Number of Derivative Securities Acquired (A) or Disposed of (D) 6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security 8. Price of Derivative Security 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) 11. Nature of Indirect Beneficial Ownership
Code V (A) (D) Date Exercisable Expriation Date Title Amount or Number of Shares

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
POHLMAN KEVIN M
822 7TH STREET, SUITE 740

GREELEY, CO80631

President - Animal Health

Signatures

Les B. Korsh, by Power of Attorney 2022-07-06
**Signature of Reporting Person Date

Explanation of Responses:

(*) If the form is filed by more than one reporting person, see Instruction 5(b)(v).
(**) Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) On July 1, 2022, the restricted stock unit ("RSU") equivalents vested per the Patterson Companies, Inc. Amended and Restated 2015 Omnibus Incentive Plan ("Plan) and were paid out in common stock. The Company withheld shares to satisfy the tax liability associated with the vesting.
(2) Includes an aggregate of 17,202 restricted stock units ("RSUs") awarded on 7/1/2017, 8/7/2017, 7/1/2018, 7/1/2019, 7/14/2020 and 7/1/2021 to Reporting Person pursuant to the Patterson Companies, Inc. Amended and Restated 2015 Omnibus Incentive Plan ("Plan"). The RSUs vest contingent upon continued employment as follows: 8,098 units vest on 7/1/2022, 191 units vest on 8/7/2022, 2,515 units vest on 7/1/2023, 4,773 units vest on 7/14/2023 and 1,625 units vest on 7/1/2024.
(3) Represents shares of common stock withheld to satisfy a portion of tax liability upon the lapse of restrictions on RSUs issued pursuant to the Plan.
(4) Includes an aggregate of 9,287 RSUs awarded on 8/7/2017, 7/1/2018, 7/1/2019, 7/14/2020 and 7/1/2021 to Reporting Person pursuant to the Plan. The RSUs vest contingent upon employment as follows: 191 units vest on 8/7/2022, 2,606 units vest 7/1/2023, 4,773 units vest 7/14/2023 and 1,717 units vest 7/1/2024.
(5) Represents RSUs awarded on 7/1/2022 to Reporting Person pursuant to the Plan. The RSUs awarded vest, assuming continued employment, 33.3% on 7/1/2023, 33.3% on 7/1/2024 and 33.4% on 7/1/2025.
(6) Represents shares of common stock indirectly held by the Reporting Person's Employee Stock Ownership Plan (ESOP) account through April 29, 2022.
(7) Stock options granted pursuant to the Plan on 7/1/2022.
(8) Options are exercisable as follows: 33.3% on 7/1/2023, 33.3% on 7/1/2024 and 33.4% on 7/1/2025.
(9) Stock options granted pursuant to the Plan on 7/1/2021.
(10) Options are exercisable as follows: 33.3% on 7/1/2022, 33.3% on 7/1/2023 and 33.4% on 7/1/2024.
(11) Stock options granted pursuant to the Plan on 7/14/2020.
(12) Options are exercisable as follows: 33.3% on 7/14/2021, 33.3% on 7/14/2022 and 33.4% on 7/14/2023.
(13) Stock options granted pursuant to the Plan on 7/1/2019.
(14) Options are exercisable as follows: 33.3% on 7/1/2020, 33.3% on 7/1/2021 and 33.4% on 7/1/2022.
(15) Stock options granted pursuant to the Plan on 7/1/2018.
(16) Stock option granted pursuant to the Plan on 8/7/2017.
(17) Stock option granted pursuant to the Plan on 7/1/2017.
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.